The Journal of Urology 2025

67 papers
The 2025 edition of The Journal of Urology includes 36 papers highlighting advancements in urological oncology, health equity, and digital health integration. Research into prostate cancer is a significant focus, with studies examining urban-rural and racial disparities in the use of intensified systemic therapies and advanced imaging like mpMRI and PET scans. Diagnostic developments include the evaluation of PSMA-PET/CT for molecular-guided nerve sparing and the use of Restriction Spectrum Imaging as a quantitative biomarker. Technological applications are also prominent, featuring the use of generative artificial intelligence for data abstraction in kidney cancer pathology and wearable devices for perioperative home monitoring. In bladder cancer, research explores the efficacy of thermosensitive liposomal doxorubicin combined with hyperthermic intravesical chemotherapy. Molecular studies investigate senescence-associated miRNA in clear cell renal cell carcinoma to better understand the tumor immune microenvironment. Prolific contributors to this year’s volume include Jeremy Yuen-Chun Teoh, Chi-Fai Ng, and Hiten D. Patel, whose work reflects a broader trend toward precision diagnostics and the reduction of healthcare disparities.

Top Research Directions

Research directions most represented by The Journal of Urology 2025 papers.

Calibrating Diagnostic Thresholds for Specific Populations 1
Mitigating Demographic Performance Disparities in Medical Imaging 1
Mitigating Inter-Observer Variability in Medical Diagnostics 1

Top Authors

AuthorPapers
Jeremy Yuen-Chun Teoh10
Alex Qinyang Liu4
Bradford J Wood2
Anobel Odisho1
Jens Kleesiek1
Qi Dou1

Papers

Title
MP37-19 COMPARATIVE COST ANALYSIS OF ROBOT-ASSISTED SIMPLE PROSTATECTOMY AND HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA
Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making
PD04-10 LEVERAGING DIGITAL PATHOLOGY FOR QUANTITATIVE GLEASON PATTERN ASSESSMENT IN PROSTATE BIOPSY SPECIMENS
PD04-10 LEVERAGING DIGITAL PATHOLOGY FOR QUANTITATIVE GLEASON PATTERN ASSESSMENT IN PROSTATE BIOPSY SPECIMENS
PD16-02 INSIGHTS FROM THE PIONEER+ BIG DATA CONSORTIUM FOR PROSTATE CANCER: BASELINE CHARACTERISTICS AND MEDICATION PROFILE VARIATIONS IN MHSPC
PD16-02 INSIGHTS FROM THE PIONEER+ BIG DATA CONSORTIUM FOR PROSTATE CANCER: BASELINE CHARACTERISTICS AND MEDICATION PROFILE VARIATIONS IN MHSPC
PD18-09 PROSTATE CANCER DETECTION AND TREATMENT AMONG NATIVE AMERICAN VETERANS
PD18-09 PROSTATE CANCER DETECTION AND TREATMENT AMONG NATIVE AMERICAN VETERANS
PD30-07 CONVENTIONAL PSMA-PET/CT, MPMRI AND INTRAOPERATIVE EX VIVO SPECIMENPET/CT FOR THE ASSESSMENT OF ACCURACY OF EXTRAPROSTATIC EXTENSION – POTENTIAL OF MOLECULAR-GUIDED NERVE SPARING
PD30-07 CONVENTIONAL PSMA-PET/CT, MPMRI AND INTRAOPERATIVE EX VIVO SPECIMENPET/CT FOR THE ASSESSMENT OF ACCURACY OF EXTRAPROSTATIC EXTENSION – POTENTIAL OF MOLECULAR-GUIDED NERVE SPARING
PD31-08 BASELINE ANTI-CHOLINERGIC BURDEN - A DETERMINANT OF ADVERSE CARDIOLOGICAL AND UROLOGICAL OUTCOMES IN OAB PATIENTS NEWLY STARTED ON ANTI-MUSCARINICS: A PROPENSITY-SCORE MATCHED ANALYSIS
PD31-08 BASELINE ANTI-CHOLINERGIC BURDEN - A DETERMINANT OF ADVERSE CARDIOLOGICAL AND UROLOGICAL OUTCOMES IN OAB PATIENTS NEWLY STARTED ON ANTI-MUSCARINICS: A PROPENSITY-SCORE MATCHED ANALYSIS
PD32-03 GENERATIVE ARTIFICIAL INTELLIGENCE APPLICATIONS IN DATA ABSTRACTION AND PATTERN ANALYSIS FOR KIDNEY CANCER PATHOLOGY REPORTS
PD32-03 GENERATIVE ARTIFICIAL INTELLIGENCE APPLICATIONS IN DATA ABSTRACTION AND PATTERN ANALYSIS FOR KIDNEY CANCER PATHOLOGY REPORTS
PD37-06 REAL-WORLD ADOPTION AND IMPACT OF NEOADJUVANT CHEMOTHERAPY ON SURVIVAL OUTCOMES IN BLADDER CANCER: A 20-YEAR FOLLOW-UP MULTI-CENTER STUDY
PD37-06 REAL-WORLD ADOPTION AND IMPACT OF NEOADJUVANT CHEMOTHERAPY ON SURVIVAL OUTCOMES IN BLADDER CANCER: A 20-YEAR FOLLOW-UP MULTI-CENTER STUDY
Prostate-Specific Antigen Density to Select Magnetic Resonance Imaging–Targeted vs Combined Biopsy for Prostate Cancer Diagnosis: A Secondary Analysis of the Trio Study

« prev Page 2/2